BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30572747)

  • 1. The neurokinin B pathway in the treatment of menopausal hot flushes.
    Anderson RA; Skorupskaite K; Sassarini J
    Climacteric; 2019 Feb; 22(1):51-54. PubMed ID: 30572747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin 3 Receptor Antagonism Reveals Roles for Neurokinin B in the Regulation of Gonadotropin Secretion and Hot Flashes in Postmenopausal Women.
    Skorupskaite K; George JT; Veldhuis JD; Millar RP; Anderson RA
    Neuroendocrinology; 2018; 106(2):148-157. PubMed ID: 28380486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurokinin 3 Receptor Antagonism: A Novel Treatment for Menopausal Hot Flushes.
    Modi M; Dhillo WS
    Neuroendocrinology; 2019; 109(3):242-248. PubMed ID: 30504731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurokinin 3 receptor antagonism - the magic bullet for hot flushes?
    Prague JK; Dhillo WS
    Climacteric; 2017 Dec; 20(6):505-509. PubMed ID: 29040006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic neurokinin signalling and its application in reproductive medicine.
    Skorupskaite K; Anderson RA
    Pharmacol Ther; 2022 Feb; 230():107960. PubMed ID: 34273412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurokinin 3 receptor antagonists - prime time?
    Prague JK
    Climacteric; 2021 Feb; 24(1):25-31. PubMed ID: 33135940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurokinin B and Neurokinin-3 Receptor Signaling: Promising Developments in the Management of Menopausal Hot Flushes.
    Modi M; Dhillo WS
    Semin Reprod Med; 2019 May; 37(3):125-130. PubMed ID: 31869840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Maione L; Christin-Maître S; Chanson P; Young J
    Ann Endocrinol (Paris); 2017 Oct; 78 Suppl 1():S31-S40. PubMed ID: 29157487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.
    Prague JK; Roberts RE; Comninos AN; Clarke S; Jayasena CN; Nash Z; Doyle C; Papadopoulou DA; Bloom SR; Mohideen P; Panay N; Hunter MS; Veldhuis JD; Webber LC; Huson L; Dhillo WS
    Lancet; 2017 May; 389(10081):1809-1820. PubMed ID: 28385352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that Neurokinin B Controls Basal Gonadotropin-Releasing Hormone Secretion but Is Not Critical for Estrogen-Positive Feedback in Sheep.
    Li Q; Millar RP; Clarke IJ; Smith JT
    Neuroendocrinology; 2015; 101(2):161-74. PubMed ID: 25677216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and treatment of hot flushes and menopausal mood disturbance.
    Joffe H; Soares CN; Cohen LS
    Psychiatr Clin North Am; 2003 Sep; 26(3):563-80. PubMed ID: 14563098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New advances in menopause symptom management.
    Koysombat K; McGown P; Nyunt S; Abbara A; Dhillo WS
    Best Pract Res Clin Endocrinol Metab; 2024 Jan; 38(1):101774. PubMed ID: 37076317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurokinin B activates arcuate kisspeptin neurons through multiple tachykinin receptors in the male mouse.
    de Croft S; Boehm U; Herbison AE
    Endocrinology; 2013 Aug; 154(8):2750-60. PubMed ID: 23744641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications.
    Szeliga A; Czyzyk A; Podfigurna A; Genazzani AR; Genazzani AD; Meczekalski B
    Gynecol Endocrinol; 2018 Nov; 34(11):913-919. PubMed ID: 29902942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hot flushes and breast cancer with positive hormone receptors: Mechanisms and management].
    Cavadias I; Rouzier R; Lerebours F; Héquet D
    Bull Cancer; 2020 Nov; 107(11):1171-1185. PubMed ID: 32988609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. κ Agonists as a novel therapy for menopausal hot flashes.
    Oakley AE; Steiner RA; Chavkin C; Clifton DK; Ferrara LK; Reed SD
    Menopause; 2015 Dec; 22(12):1328-34. PubMed ID: 25988798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neurokinin 3 receptor antagonist fezolinetant on hot flash-like symptoms in ovariectomized rats.
    Tahara A; Takamatsu H; Ohtake A; Tanaka-Amino K; Kaku S
    Eur J Pharmacol; 2021 Aug; 905():174207. PubMed ID: 34048742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurokinin B signaling in the female rat: a novel link between stress and reproduction.
    Grachev P; Li XF; Hu MH; Li SY; Millar RP; Lightman SL; O'Byrne KT
    Endocrinology; 2014 Jul; 155(7):2589-601. PubMed ID: 24708241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hot flushes and night sweats: where are we now?
    Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
    Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review.
    Menown SJ; Tello JA
    Adv Ther; 2021 Oct; 38(10):5025-5045. PubMed ID: 34514552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.